@ARTICLE{
author={Smolen Josef S,...,Ristic Gorica G,...,(broj koautora 48)},
year={2023},
title={EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={82},
number={1},
pages={3-18},
document_type={Article},
} 

@ARTICLE{
author={Smolen Josef S,Pangan Aileen L,Emery Paul,Rigby William,Tanaka Yoshiya,Vargas Juan Ignacio,Zhang Ying,Damjanov Nemanja S,Friedman Alan,Othman Ahmed A,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study},
journal={LANCET},
volume={393},
number={10188},
pages={2303-2311},
document_type={Article},
} 

@ARTICLE{
author={Smolen Josef S,...,Damjanov Nemanja S,...,(broj koautora 33)},
year={2014},
title={EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={73},
number={3},
pages={492-509},
document_type={Article},
}